Literature DB >> 26628516

Depression Symptomatology and Anterior Cruciate Ligament Injury: Incidence and Effect on Functional Outcome--A Prospective Cohort Study.

Grant H Garcia1, Hao-Hua Wu2, Min Jung Park3, Fotios P Tjoumakaris4, Bradford S Tucker4, John D Kelly5, Brian J Sennett5.   

Abstract

BACKGROUND: Recent literature has recognized a correlation with depression and poor self-reported functional outcome after orthopaedic procedures. However, the effect of depression on anterior cruciate ligament reconstruction (ACLR) outcome has never been studied.
PURPOSE: To quantify the incidence of major depressive disorder (MDD) and correlate depression symptoms with patient-rated knee function in patients undergoing ACLR. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: In this multicenter prospective cohort study, 64 consecutive adult patients undergoing primary ACLR were given the 16-item self-report Quick Inventory of Depressive Symptomatology (QIDS) to assess MDD symptoms preoperatively and at 6 weeks, 12 weeks, 24 weeks, and 1 year postoperatively. Lysholm and International Knee Documentation Committee (IKDC) subjective scores were obtained at the same time points to assess self-reported knee function. A QIDS score ≥6 served as a validated threshold for diagnosis of MDD. MDD and non-MDD group assignment was based on preoperative QIDS score. Student t test analysis was performed to compare ACLR outcomes between MDD and non-MDD patients. Correlation among QIDS, Lysholm, and IKDC scores was determined with Spearman r value.
RESULTS: A total of 27 patients (42%) were categorized in the MDD group. At baseline, the MDD group reported mean Lysholm (50.8) and IKDC (43.7) scores that were significantly lower than those (64.9 and 57.0, respectively) reported by the non-MDD group (P < .05). Both cohorts showed similar and significant absolute improvement from baseline to 1 year postoperatively (MDD vs non-MDD, increase in mean Lysholm: +24.4 vs +23.5 [P = .63]; MDD vs non-MDD, increase in mean IKDC: +28.1 vs +32.3 [P = .21]). While Lysholm and IKDC scores improved in both groups, at 1-year follow-up, MDD patients reported significantly lower mean Lysholm (75.2 vs 88.4; P = .04) and mean IKDC (71.8 vs 89.3; P = .001) scores as compared with their non-MDD counterparts. In addition, a moderate inverse correlation was found between QIDS and Lysholm scores (r = -0.50) and between QIDS and IKDC scores (r = -0.54). Interestingly, 4 patients experienced complications in the MDD cohort (15%), while there were no complications in the non-MDD group.
CONCLUSION: This study suggests that ACLR may be an equally effective intervention for MDD and non-MDD patients, given their similar significant absolute improvements in functional scores from baseline to 1 year after ACLR. However, MDD patients still reported significantly lower self-reported functional scores at baseline and 1 year postoperatively.
© 2015 The Author(s).

Entities:  

Keywords:  ACL reconstruction; MDD; anterior cruciate ligament; depression; knee ligaments

Mesh:

Year:  2015        PMID: 26628516     DOI: 10.1177/0363546515612466

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  18 in total

1.  Using Patient-reported Outcomes Measurement Information System Measures to Understand the Relationship Between Improvement in Physical Function and Depressive Symptoms.

Authors:  Casey M Beleckas; Jason Guattery; Aaron M Chamberlain; Taleef Khan; Michael P Kelly; Ryan P Calfee
Journal:  J Am Acad Orthop Surg       Date:  2018-12-15       Impact factor: 3.020

2.  A Technical Report on the Development of a Real-Time Visual Biofeedback System to Optimize Motor Learning and Movement Deficit Correction.

Authors:  Scott Bonnette; Christopher A DiCesare; Adam W Kiefer; Michael A Riley; Kim D Barber Foss; Staci Thomas; Jed A Diekfuss; Gregory D Myer
Journal:  J Sports Sci Med       Date:  2020-02-24       Impact factor: 2.988

3.  Learned Helplessness After Anterior Cruciate Ligament Reconstruction: An Altered Neurocognitive State?

Authors:  Julie P Burland; Adam S Lepley; Marc Cormier; Lindsay J DiStefano; Robert Arciero; Lindsey K Lepley
Journal:  Sports Med       Date:  2019-05       Impact factor: 11.136

4.  An Interactive Cognitive-Behavioural Multimedia Program Favourably Affects Pain and Kinesiophobia During Rehabilitation After Anterior Cruciate Ligament Surgery: An Effectiveness Trial.

Authors:  Britton W Brewer; Judy L Van Raalte; Allen E Cornelius
Journal:  Int J Sport Exerc Psychol       Date:  2021-06-01

5.  Depression and Anxiety Screening Identifies Patients That may Benefit From Treatment Regardless of Existing Diagnoses.

Authors:  Brandon Lippold; Yash R Tarkunde; Abby L Cheng; Charles P Hannon; Muyibat A Adelani; Ryan P Calfee
Journal:  Arthroplast Today       Date:  2022-03-02

6.  The Presence of Preoperative Depression Symptoms Does Not Hinder Recovery After Anterior Cruciate Ligament Reconstruction.

Authors:  Eric W Guo; Austin G Cross; Luke Hessburg; Dylan Koolmees; David N Bernstein; Kareem G Elhage; Vasilios Moutzouros; Eric C Makhni
Journal:  Orthop J Sports Med       Date:  2021-01-20

Review 7.  Depression and psychiatric disease associated with outcomes after anterior cruciate ligament reconstruction.

Authors:  Hao-Hua Wu; Max Liu; Joshua S Dines; John D Kelly; Grant H Garcia
Journal:  World J Orthop       Date:  2016-11-18

8.  Osteochondral Allograft Transplantation in Professional Athletes: Rehabilitation and Return to Play.

Authors:  Snehal Patel; Arya Amirhekmat; Ryan Le; Riley J Williams Iii; Dean Wang
Journal:  Int J Sports Phys Ther       Date:  2021-06-02

9.  Mood Disorders Are Associated with Increased Perioperative Opioid Usage and Health Care Costs in Patients Undergoing Knee Cartilage Restoration Procedure.

Authors:  Austin V Stone; Meredith L Murphy; Cale A Jacobs; Christian Lattermann; Gregory S Hawk; Katherine L Thompson; Caitlin E W Conley
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

10.  Bouncing Back.

Authors:  Edward M Wojtys
Journal:  Sports Health       Date:  2016-07       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.